Your search for oral corticosteroids returned 6 results

Findings may help with decision-making in this high-risk patient population.

Ascorbic acid level testing confirmed severe deficiency (<0.1mg/dL).

Recommendations on the management of coronavirus disease 2019 (COVID-19) were recently released by the National Institutes of Health (NIH) to help guide clinicians caring for patients with COVID-19.

The study authors aimed to assess AE risk and complications of OCS use in patients with asthma since most studies only report them in non-asthmatic patients.

The male patient presented in 2009 with a “3-year history of multiple interconnecting comedones in the axilla and inguinal regions, as well as scarring from previous lesions.”

The authors reported that ACQ scores (P=0.04) and oral corticosteroid use (P=0.04) were significantly reduced in high severity completers (n=21) receiving escitalopram.